Christophe Sauer, president at Sephire, the association of innovative pharmaceutical companies in Tunisia, talks us through the challenges that innovative MNCs are facing in the country, especially in terms of pricing, but also highlights the important efforts that have been made in public-private dialogues.
Mr. Sauer, could you please introduce Sephire to our international readers and take us back to its beginnings?
"The name Sephire comes from an Arabic word meaning “ambassador”. We are the link between the policy makers, the government and the headquarters of our companies."
